Toward intensifying design of experiments in upstream bioprocess development: An industrial Escherichia coli feasibility study
暂无分享,去创建一个
[1] Rui Oliveira,et al. Hybrid modeling as a QbD/PAT tool in process development: an industrial E. coli case study , 2016, Bioprocess and Biosystems Engineering.
[2] S. Feyo de Azevedo,et al. Bioprocess hybrid parametric/nonparametric modelling based on the concept of mixture of experts , 2008 .
[3] Carl-Fredrik Mandenius,et al. Bioprocess optimization using design‐of‐experiments methodology , 2008, Biotechnology progress.
[4] Bas Diepenbroek,et al. Multivariate PAT solutions for biopharmaceutical cultivation: current progress and limitations. , 2014, Trends in biotechnology.
[6] Mike Tobyn,et al. Multivariate analysis in the pharmaceutical industry: enabling process understanding and improvement in the PAT and QbD era , 2015, Pharmaceutical development and technology.
[7] B. Glick. Metabolic load and heterologous gene expression. , 1995, Biotechnology advances.
[8] Wolfgang Marquardt,et al. The validity domain of hybrid models and its application in process optimization , 2007 .
[9] René H. Wijffels,et al. Process analytical technology (PAT) tools for the cultivation step in biopharmaceutical production , 2013 .
[10] A. Rathore,et al. Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.
[11] Rui Oliveira,et al. Bioprocess Iterative Batch‐to‐Batch Optimization Based on Hybrid Parametric/Nonparametric Models , 2006, Biotechnology progress.
[12] R. Simutis,et al. Avoiding overfeeding in high cell density fed-batch cultures of E. coli during the production of heterologous proteins. , 2014, Journal of biotechnology.
[13] S. Jørgensen,et al. A biochemically structured model for Saccharomyces cerevisiae. , 2001, Journal of biotechnology.
[14] J. Heijnen,et al. Understanding and applying the extrapolation properties of serial gray-box models , 1998 .
[15] Lyle H. Ungar,et al. A hybrid neural network‐first principles approach to process modeling , 1992 .
[16] Rui Oliveira. Combining first principles modelling and artificial neural networks: a general framework , 2004, Comput. Chem. Eng..
[17] Guidance for Industry PAT — A Framework for Innovative Pharmaceutical Development , Manufacturing , and Quality Assurance , 2004 .
[18] R. Simutis,et al. Selective expression of the soluble product fraction in Escherichia coli cultures employed in recombinant protein production processes , 2010, Applied Microbiology and Biotechnology.
[19] Mitchell Tai,et al. Efficient high‐throughput biological process characterization: Definitive screening design with the Ambr250 bioreactor system , 2015, Biotechnology progress.
[20] Oliver Spadiut,et al. A dynamic method based on the specific substrate uptake rate to set up a feeding strategy for Pichia pastoris , 2011, Microbial cell factories.
[21] P. Hagander,et al. Avoiding acetate accumulation in Escherichia coli cultures using feedback control of glucose feeding. , 2001, Biotechnology and bioengineering.
[22] R. Simutis,et al. Product formation kinetics in genetically modified E. coli bacteria: inclusion body formation , 2008, Bioprocess and biosystems engineering.
[23] Sebastião Feyo de Azevedo,et al. Hybrid semi-parametric modeling in process systems engineering: Past, present and future , 2014, Comput. Chem. Eng..
[24] Wee Chew,et al. Trends in process analytical technology , 2010 .
[25] Carl-Fredrik Mandenius,et al. Process analytical technology (PAT) for biopharmaceuticals , 2011, Biotechnology journal.
[26] Rui Oliveira,et al. Hybrid modeling for quality by design and PAT-benefits and challenges of applications in biopharmaceutical industry. , 2014, Biotechnology journal.
[27] Margaret J. Robertson,et al. Design and Analysis of Experiments , 2006, Handbook of statistics.
[28] K. Shimizu. Metabolic Regulation of a Bacterial Cell System with Emphasis on Escherichia coli Metabolism , 2013, ISRN biochemistry.